Auxellence Announces Reviewing Options for a Dual Listing in the USA.

Loading...
Loading...

VANCOUVER, BC, / ACCESSWIRE / October 2, 2014 / Auxellence Health Corporation AID announces that it is reviewing options to pursue a dual listing on a US market or exchange platform to potentially increase the company's visibility for both shareholders and its technology. The company will provide further updates in regards to its progress, as it becomes available.

Contact:

Sydney Au, CEO

Auxellence Health Corporation

Email: ceo@auxellence.com

Phone: (604) 780-3311

About Auxellence Health Corporation AID

Auxellence is a technology company engaged in the provision of biomedical online services for common health problems. The company offers an extensive platform for physiologically interactive computing supporting therapeutic-diagnostic (theranostic) devices, expert systems, and recommender applications for personal health management. The initial focus is on weight management and skin conditions.

Disclaimer for Forward-Looking Information

Statements in this press release regarding the Company which are not historical facts are "forward-looking statements" that involve risks and uncertainties. Such information can generally be identified by the use of forwarding-looking wording such as "may", "will", "expect", "estimate", "anticipate", "intend", "believe" and "continue" or the negative thereof or similar variations. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated in such statements due to factors. The Company does not intend to update any changes to such statements, except as required by law. Although Management believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

THIS PRESS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES 

SOURCE: Auxellence Health Corporation   

Loading...
Loading...
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...